These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 23395419)

  • 1. Add-on filgrastim during clozapine rechallenge unsuccessful in preventing agranulocytosis.
    Hazewinkel AW; Bogers JP; Giltay EJ
    Gen Hosp Psychiatry; 2013; 35(5):576.e11-2. PubMed ID: 23395419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
    Hägg S; Rosenius S; Spigset O
    Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Add-on filgrastim during clozapine rechallenge in patients with a history of clozapine-related granulocytopenia/agranulocytosis.
    Joffe G; Eskelinen S; Sailas E
    Am J Psychiatry; 2009 Feb; 166(2):236. PubMed ID: 19188296
    [No Abstract]   [Full Text] [Related]  

  • 4. Failure of filgrastim to prevent severe clozapine-induced agranulocytosis.
    Majczenko TG; Stewart JT
    South Med J; 2008 Jun; 101(6):639-40. PubMed ID: 18475227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating chemotherapy induced agranulocytosis with granulocyte colony-stimulating factors in a patient on clozapine.
    Kolli V; Denton K; Borra D; Pulluri M; Sharma A
    Psychooncology; 2013 Jul; 22(7):1674-5. PubMed ID: 23059755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of clozapine-induced agranulocytosis with recombinant granulocyte colony-stimulating factor.
    Gullion G; Yeh HS
    J Clin Psychiatry; 1994 Sep; 55(9):401-5. PubMed ID: 7523362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Filgrastim treatment of three patients with clozapine-induced agranulocytosis.
    Lamberti JS; Bellnier TJ; Schwarzkopf SB; Schneider E
    J Clin Psychiatry; 1995 Jun; 56(6):256-9. PubMed ID: 7539786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine re-challenge under the cover of Filgrastim.
    Gopalakrishnan R; Subhalakshmi TP; Kuruvilla A; Jacob KS
    J Postgrad Med; 2013; 59(1):54-5. PubMed ID: 23525060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of clozapine- and molindone-induced agranulocytosis with granulocyte colony-stimulating factor.
    Geibig CB; Marks LW
    Ann Pharmacother; 1993 Oct; 27(10):1190-4. PubMed ID: 7504534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Agranulocytosis caused by clozapine: the importance of leukocyte monitoring and efficacy of hematopoietic growth factors].
    van Melick EJ; Touw DJ; Haak HL
    Ned Tijdschr Geneeskd; 1995 Nov; 139(47):2437-40. PubMed ID: 8524426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of agranulocytosis secondary to rechallenge with clozapine following severe neutropenia during previous therapy.
    Lertxundi U; Sanchez P; Hernandez R; Elizagarate E
    J Clin Psychiatry; 2011 Dec; 72(12):1659. PubMed ID: 22244024
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant human granulocyte colony-stimulating factor (rhG-CSF; filgrastim) treatment of clozapine-induced agranulocytosis.
    Nielsen H
    J Intern Med; 1993 Nov; 234(5):529-31. PubMed ID: 7693847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. As-Required Filgrastim for Late-Onset Neutropenia Complicating Long-Term Clozapine Treatment: a Case Report.
    Chan KSW; Lai NBW; Wong MMC; Pang PF
    East Asian Arch Psychiatry; 2023 Mar; 33(1):28-31. PubMed ID: 36991553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic dilemmas in treatment-resistant bipolar patients.
    Bota RG; Sagduyu K
    South Med J; 2008 Jun; 101(6):584. PubMed ID: 18475231
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clozapine rechallenge in resistant schizophrenia disorder affecting "super sensitive" patients, after neutropenia under clozapine: a case report].
    Huguet G; Lillo-Le Louet A; Darnige L; Loo H; Krebs MO
    Encephale; 2013 May; 39 Suppl 1():S42-8. PubMed ID: 23557674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of clozapine-induced granulocytopenia/agranulocytosis with granulocyte-colony stimulating factor (G-CSF) in an intellectually disabled patient with schizophrenia.
    Rajagopal G; Graham JG; Haut FF
    J Intellect Disabil Res; 2007 Jan; 51(Pt 1):82-5. PubMed ID: 17181606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of cytokines in clozapine-induced agranulocytosis.
    Chin-Yee I; Bezchlibnyk-Butler K; Wong L
    Can J Psychiatry; 1996 Jun; 41(5):280-4. PubMed ID: 8793147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G-CSF Dosing to Prevent Recurrent Clozapine-Induced Agranulocytosis.
    Freeman GM; Martin BA; Hu RJ
    Am J Psychiatry; 2016 Jun; 173(6):643. PubMed ID: 27245191
    [No Abstract]   [Full Text] [Related]  

  • 19. Clozapine-induced agranulocytosis: a case report. Immunopathophysiological considerations.
    van de Loosdrecht AA; Faber HJ; Hordijk P; Uges DR; Smit A
    Neth J Med; 1998 Jan; 52(1):26-9. PubMed ID: 9573739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations.
    Myles N; Myles H; Clark SR; Bird R; Siskind D
    Aust N Z J Psychiatry; 2017 Oct; 51(10):980-989. PubMed ID: 28747065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.